Isabel Vivas Pérez-rekin lankidetzan egindako argitalpenak (5)

2020

  1. Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy

    Radiologia, Vol. 62, Núm. 2, pp. 131-138

2008

  1. CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC)

    Lung Cancer, Vol. 61, Núm. 2, pp. 209-213

  2. Oxaliplatin plus gemcitabine as a salvage schedule for hormone-refractory prostate adenocarcinoma

    Clinical and Translational Oncology, Vol. 10, Núm. 6, pp. 372-374

2004

  1. Percutaneous CT-guided 103Pd implantation for the medically inoperable patient with T1N0M0 non-small cell lung cancer: A case report

    Brachytherapy, Vol. 3, Núm. 3, pp. 179-181

2000

  1. Reacciones adversas a los medios de contraste yodados en pacientes tratados con interleuquina 2

    Radiologia, Vol. 42, Núm. 7, pp. 393-396